Drew Amorosi

Managing Editor

Preston's Summary

Drew Amorosi is a managing editor at Healio | HemOnc Today. He specializes in hematology, oncology, and cellular therapy, drawing on his extensive background in health and medicine journalism. Amorosi's work has been recognized with multiple awards, including features in Healio and SPIRIT MEDIA GROUP.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Collingdale, United States (Local)

Coverage Attributes:

Beta
Informative: 55 %
Events: 26 %
Opinion: 6 %
Data Driven: 6 %
Interviews Q&as: 4 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Court Proceedings
  • Legal Reform
  • Consumer Health

Pitching Insights

Drew Amorosi's coverage primarily focuses on healthcare and pharmaceuticals, often citing data and press releases. He may be interested in pitches related to new scientific research, breakthrough treatments, or innovative therapies within the field of cancer treatment and precision medicine.

Given his focus on racial disparities in cancer treatment and specific diseases such as breast cancer, sickle cell disease, multiple myeloma, etc., Drew would likely welcome pitches that highlight efforts to address these disparities or advancements in treating these conditions.

As there is no specified geographic focus for Drew's articles, sources with a global perspective or those involved in international medical studies could be relevant for reaching out to him.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data